Results
1
Companies which are more than 50% undervalued based on analyst price target.
1 companies
Biome Australia
Market Cap: AU$102.6m
Engages in the development, commercialization, and marketing of various live biotherapeutics and complimentary medicines in Australia and internationally.
BIO
AU$0.47
7D
1.1%
1Y
-35.9%